Paul C. Lorigan
Paul C. Lorigan publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways and Cutaneous Melanoma Detection and Management.
- World rank
- #173,621 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #15,700 of 367,258
- Works
- 686
- Citations
- 65k
- Citations per work
- 94.7
What does Paul C. Lorigan research?
Paul C. Lorigan's work is mostly in Medicine (52%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences35551.8%
- Medicine35551.8%
- Life Sciences18426.8%
- Everything else14721.4%
- 1Oncology39% of their works
- 2Molecular Biology17% of their works
- 3Pulmonary and Respiratory Medicine8% of their works
- 4Immunology7% of their works
- 5Epidemiology4% of their works
- 6Cancer Research3% of their works
Research topics
Which keywords describe Paul C. Lorigan's research?
The keywords of their largest research topics: Immunotherapy, Melanoma, Survival Analysis, Immune Checkpoint Blockade, PD-1 and PD-L1, BRAF gene, Cancer Immunotherapy and MAP Kinase.
- Pancreatic Neuroendocrine Tumors
- EGFR Mutations
- Immunity
- Small-Cell Lung Cancer
- Chimeric Antigen Receptor
- Targeted Therapy
- Skin Cancer
- MAP Kinase
- BRAF gene
- Immune Checkpoint Blockade
- Melanoma
- Immunotherapy
- Survival Analysis
- PD-1 and PD-L1
- Cancer Immunotherapy
- Dermoscopy
- Clinical Trials
- CAR T Cells
- Genomic Profiles
- Dendritic Cells
- ALK Inhibitors
- Neuroendocrine Tumors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Immunotherapy3623 topics
- Melanoma3482 topics
- Survival Analysis2112 topics
- Immune Checkpoint Blockade1861 topic
- PD-1 and PD-L11861 topic
- BRAF gene1821 topic
- Cancer Immunotherapy1822 topics
- MAP Kinase1821 topic
- Dermoscopy1661 topic
- Skin Cancer1661 topic
- Clinical Trials1622 topics
- Targeted Therapy1622 topics
- CAR T Cells1061 topic
- Chimeric Antigen Receptor1061 topic
- Genomic Profiles901 topic
- Small-Cell Lung Cancer901 topic
- Dendritic Cells761 topic
- Immunity761 topic
- ALK Inhibitors721 topic
- EGFR Mutations721 topic
- Neuroendocrine Tumors451 topic
- Pancreatic Neuroendocrine Tumors451 topic
Where does Paul C. Lorigan work?
Paul C. Lorigan's main affiliation in the publication record is The Christie NHS Foundation Trust, United Kingdom.
How many publications and citations does Paul C. Lorigan have?
OpenAlex counts 686 works and 64,948 citations for Paul C. Lorigan, an h-index of 89, ranking #173,621 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Paul C. Lorigan
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Paul C. Lorigan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.